Evaluation of the CpG island methylator phenotype as a predictive biomarker for adjuvant oxaliplatin-based chemotherapy in colorectal cancer.

被引：0
|
作者：
Shiovitz, Stacey
Wu, Chen
Yu, Ming
Gourgioti, Georgia
Raptou, Georgia
Kotoula, Vassiliki
Pentheroudakis, George E.
Kalogeras, Konstantine T.
Fountzilas, George
Grady, William M.
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Hellen Cooperat Oncol Grp, Athens, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, GR-54006 Thessaloniki, Greece
[4] Hellen Fdn Canc Res, Mol Oncol Lab, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.592
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
592
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin
    Cohen, Stacey A.
    Wu, Chen
    Yu, Ming
    Gourgioti, Georgia
    Wirtz, Ralph
    Raptou, Georgia
    Gkakou, Chryssa
    Kotoula, Vassiliki
    Pentheroudakis, George
    Papaxoinis, George
    Karavasilis, Vasilios
    Pectasides, Dimitrios
    Kalogeras, Konstantine T.
    Fountzilas, George
    Grady, William M.
    CLINICAL COLORECTAL CANCER, 2016, 15 (02) : 164 - 169
  • [2] Reinduction of oxaliplatin-based chemotherapy after exposure to oxaliplatin in adjuvant setting for colorectal cancer.
    Beom, Seung-Hoon
    Ahn, Joong Bae
    Shin, Sang Joon
    Jung, Minkyu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [3] CpG island methylator phenotype in colorectal cancer
    Toyota, M
    Ahuja, N
    Ohe-Toyota, M
    Herman, JG
    Baylin, SB
    Issa, JPJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) : 8681 - 8686
  • [4] The prognostic role of CpG island methylator phenotype in metastatic colorectal cancer.
    Chen, Kuo-Hsing
    Lin, Liang-In
    Tseng, Li-Hui
    Lin, Yu-Lin
    Liau, Jau-Yu
    Tsai, Jia-Huei
    Liang, Jin-Tung
    Lin, Been-Ren
    Cheng, Ann-Lii
    Yeh, Kun-Huei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] The CpG island methylator phenotype in colorectal cancer
    Samowitz, Wade S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (03): : 281 - 283
  • [6] Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy
    Gallois, C.
    Taieb, J.
    Le Corre, D.
    Le Malicot, K.
    Tabernero, J.
    Mulot, C.
    Seitz, J-F.
    Aparicio, T.
    Folprecht, G.
    Lepage, C.
    Mini, E.
    Van Laethem, J-L.
    Emile, J. F.
    Laurent-Puig, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy
    Gallois, Claire
    Taieb, Julien
    Le Corre, Delphine
    Le Malicot, Karine
    Tabernero, Josep
    Mulot, Claire
    Seitz, Jean-Francois
    Aparicio, Thomas
    Folprecht, Gunnar
    Lepage, Come
    Mini, Enrico
    Van Laethem, Jean-Luc
    Emile, Jean-Francois
    Laurent-Puig, Pierre
    CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4745 - 4753
  • [8] The Origin of Colorectal Cancer With CpG Island Methylator Phenotype
    Yamamoto, Eiichiro
    Suzuki, Hiromu
    Yamano, Hiro-o
    Kamimae, Seiko
    Sugai, Tamotsu
    Imai, Kohzoh
    Shinomura, Yasuhisa
    Toyota, Minoru
    GASTROENTEROLOGY, 2010, 138 (05) : S562 - S562
  • [9] The origin of colorectal cancer with CpG island methylator phenotype
    Toyota, Minoru
    Yamamoto, Eiichiro
    Suzuki, Hiromu
    Kamimae, Seiko
    Yamano, Hiro-o
    Shinomura, Yasuhisa
    Innai, Kohzoh
    CANCER RESEARCH, 2010, 70
  • [10] CPG ISLAND METHYLATOR PHENOTYPE IS ASSOCIATED WITH THE EFFICACY OF CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Shimodaira, H.
    Zhang, X.
    Komine, K.
    Takahashi, M.
    Takahashi, S.
    Ishioka, C.
    ANNALS OF ONCOLOGY, 2014, 25
12345